Healthcare

Paradigm Health adds former US Secretary of Veterans Affairs, Dr. David Shulkin, to advisory board and ramps up AI-driven efforts to bring cancer clinical trials to rural America

COLUMBUS, Ohio, March 6, 2025 /PRNewswire/ -- Today, clinical trials dramatically underrepresent patients who live in rural areas of the...

Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment...

Cosmo Pharmaceuticals Delivers Record 2024 Results – Completes Phase III Enrollment for Androgenetic Alopecia in Males – Proposes Increased Dividend of 2.05 per share – Reinforcing Shareholder Value and Growth Momentum into 2025

Nationally-Recognized Health Care Providers, Leading Academics and State Leaders Address Access to Cancer Treatment in Florida’s Rural Communities

Tampa General Hospital Cancer Institute hosted a day of keynotes, presentations and discussions at TGH Brooksville to address the challenges...

New Study Demonstrates Potential for Enhanced Accuracy of Blood Cultures with Steripath® Initial Specimen Diversion Device® (ISDD®) for Central Line Draws

SEATTLE, March 5, 2025 /PRNewswire/ -- Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device® (ISDD®) technology, today...

error: Content is protected !!